Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers

Table 1

Characteristics of Study Centers	Centers
Impella devices used (n=65)
2.5	50 (76.9%)
5.0	40 (61.5%)
CP	41 (63.1%)
RP	28 (43.1%)
Indications for Impella use (n=65)
Acute decompensated heart failure/cardiogenic shock	59 (90.8%)
High-risk percutaneous intervention	53 (81.5%)
Acute coronary syndromes	39 (60.0%)
Cardiac arrest	20 (30.8%)
Other ventricular arrhythmias	14 (21.5%)
Other	3 (4.6%)